In addition to liver fibrosis, our findings that GDF-15 concentrations were significantly increased in patients with NAFLD and T2DM compared to those without T2DM, are consistent with various previous studies indicating that GDF-15 concentrations are increased in patients with T2DM [7, 26, 27]. This evidence concerns the gene GDF15 and Hepatic fibrosis.